SCHEMBL16883560

SCHEMBL16883560

Brc1cccc2c1Oc1cc3ccccc3c3cccc-2c13

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.49
▸ HSD17B10 Q99714 5/20 0.49
▸ MAPK1 P28482 4/20 0.49
▸ TSHR P16473 3/20 0.49
▸ HPGD P15428 3/20 0.49
▸ HIF1A Q16665 3/20 0.49
▸ CASP1 P29466 2/20 0.49
▸ L3MBTL1 Q9Y468 2/20 0.49
▸ MAOA P21397 4/20 0.38
▸ CYP1A2 P05177 3/20 0.38
▸ ATM Q13315 2/20 0.38
▸ ERBB2 P04626 1/20 0.38
▸ FYN P06241 1/20 0.38
▸ ACHE P22303 1/20 0.38
▸ AHR P35869 1/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ HKDC1 Q2TB90 1/20 0.37
▸ TP53 P04637 1/20 0.34
▸ CASP7 P55210 1/20 0.34
▸ MAOB P27338 3/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15600543 0.82 ALDH1A1 (0.49) ALDH1A1HSD17B10MAPK1TSHRHPGD
SCHEMBL15893312 0.82 ALDH1A1 (0.49) ALDH1A1HSD17B10MAPK1TSHRHPGD
SCHEMBL15856976 0.79 ALDH1A1 (0.46) ALDH1A1HSD17B10MAPK1TSHRHPGD
SCHEMBL15600558 0.79 ALDH1A1 (0.46) ALDH1A1HSD17B10MAPK1TSHRHPGD
SCHEMBL15600574 0.79 ALDH1A1 (0.46) ALDH1A1HSD17B10MAPK1TSHRHPGD
SCHEMBL15600432 0.79 MAPK1 (0.61) ALDH1A1HSD17B10MAPK1TSHRHPGD
SCHEMBL15600552 0.78 ALDH1A1 (0.45) ALDH1A1HSD17B10MAPK1TSHRHPGD
SCHEMBL17167442 0.78 MAPK1 (0.45) ALDH1A1HSD17B10MAPK1TSHRHPGD
SCHEMBL15945925 0.78 ALDH1A1 (0.45) ALDH1A1HSD17B10MAPK1TSHRHPGD
SCHEMBL15600489 0.77 MAPK1 (0.44) ALDH1A1HSD17B10MAPK1TSHRHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150194609-A1 DIBENZOXANTHENE COMPOUND, ORGANIC LIGHT-EMITTING DEVICE, DISPLAY, IMAGE INFORMATION PROCESSOR, AND IMAGE-FORMING APPARATUS CANON KABUSHIKI KAISHA (JP) 2015-07-09 — — US disclosed
US-20150194609-A1 DIBENZOXANTHENE COMPOUND, ORGANIC LIGHT-EMITTING DEVICE, DISPLAY, IMAGE INFORMATION PROCESSOR, AND IMAGE-FORMING APPARATUS CANON KABUSHIKI KAISHA (JP) 2015-07-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150194609-A1 DIBENZOXANTHENE COMPOUND, ORGANIC LIGHT-EMITTING DEVICE, DISPLAY, IMAGE INFORMATION PROCESSOR, AND IMAGE-FORMING APPARATUS CCNT1, CCNA1, CCND1 ALDH1A1 326/4885HSD17B10 715/4885MAPK1 338/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback